VitaSpring Biomedical Co. Ltd. (VSBC)
USD 16.0
(0.0%)
USD 16.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | 84.81 Thousand | -42.13 Thousand | -105.00 | -34.24 Thousand | 401.00 |
| Net Income | - | 1.26 Million | -425.38 Thousand | 6919.00 | -22.39 Thousand | -6374.00 |
| Depreciation & Amortization | - | 8361.00 | - | 450.00 | 450.00 | 375.00 |
| Deferred income taxes | - | 6181.00 | - | - | - | - |
| Stock-based compensation | - | 167.17 Thousand | 434.21 Thousand | - | - | - |
| Change in working capital | - | -1.36 Million | -50.96 Thousand | 9901.00 | -12.3 Thousand | 6400.00 |
| Other non-cash items | - | 1.74 Million | 578.21 Thousand | -17.37 Thousand | 4992.00 | 5150.00 |
| Investing Cash Flow | - | -72.99 Thousand | - | - | - | -2249.00 |
| Investments in PPE | - | -72.99 Thousand | - | - | - | -2249.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -2249.00 |
| Financing Cash Flow | - | 50 Thousand | 87.52 Thousand | - | 29.14 Thousand | 6500.00 |
| Debt repayment | - | - | - | - | -10.25 Thousand | -6500.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -3498.00 | - | - | - |
| Common Stock Issuance | - | 50 Thousand | 82.34 Thousand | - | 18.89 Thousand | - |
| Other Financing Activities | - | 50 Thousand | 8684.00 | - | 29.14 Thousand | 6500.00 |
| Accounts receivables | - | -2.95 Million | - | - | - | - |
| Accounts payables | - | 1.25 Million | - | - | -1410.00 | 1410.00 |
| Inventory | - | 144 Thousand | -144 Thousand | 8492.00 | -2682.00 | -5810.00 |
| Other working capital | - | 195.61 Thousand | 93.03 Thousand | 1409.00 | -8210.00 | 10.8 Thousand |
| Cash at beginning of period | 107.21 Thousand | 45.39 Thousand | - | 105.00 | 5207.00 | 555.00 |
| Cash at end of period | 107.21 Thousand | 107.21 Thousand | 45.39 Thousand | - | 105.00 | 5207.00 |
| Capital Expenditure | - | -72.99 Thousand | - | - | - | -2249.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 61.81 Thousand | 45.39 Thousand | -105.00 | -5102.00 | 4652.00 |
| Free Cash Flow | - | 11.81 Thousand | -42.13 Thousand | -105.00 | -34.24 Thousand | -1848.00 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | -138.28 Thousand |
| Depreciation & Amortization | - | - | - | - | - | 3766.00 |
| Deferred income taxes | - | - | - | - | - | -6935.00 |
| Stock-based compensation | - | - | - | - | - | 36.5 Thousand |
| Change in working capital | - | - | - | - | - | 107.4 Thousand |
| Other non-cash items | - | - | - | - | - | -61.35 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | 100 Thousand |
| Accounts payables | - | - | - | - | - | 28.8 Thousand |
| Inventory | - | - | - | - | - | -28.8 Thousand |
| Other working capital | - | - | - | - | - | 7401.00 |
| Cash at beginning of period | - | - | - | 107.21 Thousand | 24.05 Thousand | 21.59 Thousand |
| Cash at end of period | - | - | - | 107.21 Thousand | 24.05 Thousand | 24.05 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | 2460.00 |
| Free Cash Flow | - | - | - | - | - | 2460.00 |
5930
RTNB
9534
300650
RNLSY
AETHER